featured
Shifting Sands: Preventing CVD in Type 2 Diabetes
Interview by
Interview with
Interview with
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Fox CS, Golden SH, Anderson C, et al. Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38(9):1777-1803.
- Zinman B, Wanner C, Lachin JM, et al for the EMPA-REG OUTCOME Investigators. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [published online September 17, 2015]. N Engl J Med. DOI: 10.1056/NEJMoa1504720.
- The Action to Control Cardiovascular Risk in Diabetes Study Group, Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med. 2008; 358(24):2545-2559.
- 4. National Institutes of Health. Landmark NIH study shows intensive blood pressure management may save lives [press release]. September 11, 2015. http://www.nhlbi.nih.gov/news/press-releases/2015/landmark-nih-study-shows-intensive-blood-pressure-management-may-save-lives. Accessed October 28, 2015.
- Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes N Engl J Med. 2015 Jun 18;372(25):2387-9237.
Disclosure statements are available on the authors' profiles: